Title
Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial.
Document Type
Article
Publication Date
2-8-2021
Publication Title
JACC Cardiovasc Interv
Keywords
st. joseph southern california; orange; SJH
Abstract
OBJECTIVES: This study sought to prospectively evaluate the safety and efficacy of the Indigo aspiration system in submassive acute pulmonary embolism (PE).
BACKGROUND: PE treatment with thrombolytics has bleeding risks. Aspiration thrombectomy can remove thrombus without thrombolytics, but data are lacking.
METHODS: This study was a prospective, single-arm, multicenter study that enrolled patients with symptomatic acute PE ≤14 days, systolic blood pressure ≥90 mm Hg, and right ventricular-to-left ventricular (RV/LV) ratio >0.9. The primary efficacy endpoint was change in RV/LV ratio from baseline to 48 h post-procedure on core lab-adjudicated computed tomography angiography. The primary safety endpoint was a composite of 48-h major adverse events: device-related death, major bleeding, and device-related serious adverse events (clinical deterioration, pulmonary vascular, or cardiac injury). All sites received Institutional Review Board approval.
RESULTS: A total of 119 patients (mean age 59.8 ± 15.0 years) were enrolled at 22 U.S. sites between November 2017 and March 2019. Median device insertion to removal time was 37.0 (interquartile range: 23.5 to 60.0) min. Two (1.7%) patients received intraprocedural thrombolytics. Mean RV/LV ratio reduction from baseline to 48 h post-procedure was 0.43 (95% confidence interval: 0.38 to 0.47; p < 0.0001). Two (1.7%) patients experienced 3 major adverse events. Rates of cardiac injury, pulmonary vascular injury, clinical deterioration, major bleeding, and device-related death at 48 h were 0%, 1.7%, 1.7%, 1.7%, and 0.8%, respectively.
CONCLUSIONS: In this prospective, multicenter study the Indigo aspiration system was associated with a significant reduction in the RV/LV ratio and a low major adverse event rate in submassive PE patients. Intraprocedural thrombolytic drugs were avoided in 98.3% of patients. (Evaluating the Safety and Efficacy of the Indigo aspiration system in Acute Pulmonary Embolism [EXTRACT-PE]; NCT03218566).
Clinical Institute
Cardiovascular (Heart)
Department
Cardiology
Department
Pulmonary Medicine
Department
Diagnostic Imaging
Recommended Citation
Sista, Akhilesh K; Horowitz, James M; Tapson, Victor F; Rosenberg, Michael; Elder, Mahir D; Schiro, Brian J; Dohad, Suhail; Amoroso, Nancy E; Dexter, David J; Loh, Christopher T; Leung, Daniel A; Bieneman, Bruce Kirke; Perkowski, Paul E; Chuang, Michael L; Benenati, James F; and EXTRACT-PE Investigators, "Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial." (2021). Articles, Abstracts, and Reports. 4317.
https://digitalcommons.providence.org/publications/4317
